Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences

Newswire.ca - Mon Feb 26, 2024

HAMILTON, ON and BOSTON, Feb. 26, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in two upcoming investor conferences.

Read more at newswire.ca